WITHDRAWN: Foxp3 attenuates cerebral ischemia/reperfusion injury through microRNA-150-5p-modified NCS1

Zhen Gu1, Yajie Li1, Liang Zhang2

  • 1Department of Neurosurgery, The Affiliated Hospital of Yunnan University, Kunming, 650011, Yunnan, China.

Experimental Cell Research
|November 25, 2021
PubMed
Abstract

Insights

Forkhead box P3 (Foxp3) protects the brain from cerebral ischemia/reperfusion injury (CI/RI) by regulating microRNA-150-5p and nucleobase cation symporter-1 (NCS1). This pathway reduces neuronal damage and inflammation, improving neurological function after stroke.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pathology

Background:

  • Cerebral ischemia/reperfusion injury (CI/RI) involves complex molecular pathways.
  • The role of forkhead box P3 (Foxp3) in CI/RI is not fully understood.
  • The microRNA-150-5p (miR-150-5p) and nucleobase cation symporter-1 (NCS1) axis is implicated in cellular processes.

Purpose of the Study:

  • To investigate the role of Foxp3 in CI/RI.
  • To elucidate the involvement of the miR-150-5p/NCS1 axis in CI/RI.
  • To determine the regulatory relationship between Foxp3, miR-150-5p, and NCS1 in CI/RI.

Main Methods:

  • A mouse model of cerebral ischemia/reperfusion injury was established using middle cerebral artery occlusion (MCAO).
  • Levels of Foxp3, miR-150-5p, and NCS1 were measured in brain tissues.
  • Neurological function, brain pathology, neuronal apoptosis, inflammation, and oxidative stress were assessed to evaluate the roles of Foxp3, miR-150-5p, and NCS1.

Main Results:

  • Foxp3 and NCS1 levels decreased, while miR-150-5p levels increased in MCAO mice.
  • Foxp3 directly targets NCS1 via miR-150-5p.
  • Upregulating Foxp3 or NCS1, or downregulating miR-150-5p, ameliorated neurological deficits and reduced CI/RI-induced damage, apoptosis, inflammation, and oxidative stress.

Conclusions:

  • Foxp3 exhibits neuroprotective effects in CI/RI.
  • Foxp3 promotes NCS1 expression by interacting with miR-150-5p.
  • Targeting the Foxp3/miR-150-5p/NCS1 pathway may offer therapeutic strategies for CI/RI.

Related Concept Videos